Wockhardt's Novel Antibiotic Zaynich Receives FDA Approval for Complicated UTIs

The U.S. FDA has granted approval to Zaynich (cefepime and zidebactam), a new intravenous antibiotic developed by Wockhardt. This drug is intended for treating complicated urinary tract infections, including pyelonephritis, caused by susceptible Gram-negative pathogens. Its approval is crucial for addressing multidrug-resistant bacterial infections, an area with limited therapeutic options.